Navigation Links
PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
Date:8/20/2007

apan. Medicine (Baltimore). 2004;83:193-207.

(8) Gralnick HR, Vail M, McKeown LP et al. Activated platelets in

paroxysmal nocturnal haemoglobinuria. Br J Haematol. 1995;91:697-702.

(9) Audebert HJ, Planck J, Eisenburg M, Schrezenmeier H, Haberl RL.

Cerebral ischemic infarction in paroxysmal nocturnal hemoglobinuria

report of 2 cases and updated review of 7 previously published

patients. J Neurol. 2005;252:1379-1386.

(10) Hall C, Richards S, Hillmen P. Primary prophylaxis with warfarin

prevents thrombosis in paroxysmal nocturnal haemoglobinuria (PNH).

Blood. 2003;102:3587-3591.

(11) Rosse WF, Nishimura J. Clinical manifestations of paroxysmal

nocturnal hemoglobinuria: present state and future problems. Int J

Hematol. 2003;77:113-120.

(12) Luzzatto L, Gianfaldoni G. Recent advances in biological and clinical

aspects of paroxysmal nocturnal hemoglobinuria. Int J Hematol.

2006;84:104-112.

(13) Hill A, Platts PJ, Smith A et al. The incidence and prevalence of

paroxysmal nocturnal hemoglobinuria (PNH) and survival of patients in

Yorkshire [abstract]. Blood. 2006;108(11):290a. Abstract 985.

(14) Johnson RJ, Hillmen P. Paroxysmal nocturnal hemoglobinemia: Nature's

gene therapy? J Clin Path: Mol Pathol. 2002;55:145-152.

(15) Wang, et al. Clinical significance of a minor population of

paroxysmal nocturnal hemoglobinuria-type cells in bone marrow failure

syndrome. Blood 2002;100:3897-3902.

(16) Iwanga, et al. Paroxysmal nocturnal haemoglobinuria clones in

patients with myelodysplastic syndromes. Brit J Haem. 1998;

102:465-474.

(17) Maciejewski, et al. Relationship between bone marrow failure

syndromes and the presence of glycophosphatidyl inositol-anchored

protein-deficient clones. Brit J Haem. 2001;115:1015
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
2. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
3. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
4. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
5. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
6. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
7. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
8. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
9. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
10. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
11. Skin Rash Actually Signifies Better Outcomes for Pancreatic and Lung Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Dec. 18, 2014  Sage Analytics ( www.sageanalytics.com ... equipment for the testing of marijuana potency and ... new Luminary™ Profiler, the industry,s first product suite ... a cost-effective, portable unit. Designed from ... of the cannabis industry, the Luminary™ Profiler utilizes ...
(Date:12/19/2014)... INC. (NYSE: RMD ) today announced that it ... on Thursday, January 22, 2015, after the New York Stock ... be issued after 1:00 p.m. US Pacific Time and the ... future outlook. The earnings call is scheduled to ... webcast of the call can be accessed on ResMed,s Investor ...
(Date:12/19/2014)... KANSAS CITY, Kan. , Dec. 18, 2014 ... PETX ), a biopharmaceutical company focused on ... for companion animals, today announced positive results from ... company,s innovative drug for treating pain in dogs ... demonstrated improvements in pain assessment scores that were ...
Breaking Medicine Technology:Sage Analytics Develops Breakthrough System for Potency Testing of Cannabis Products 2ResMed To Announce Second Quarter 2015 Results 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5
... Jan. 28 Some 18-20 million Americans are at ... to 10 percent have been diagnosed.  Studies prove that fatality is ... OSA can be readily and successfully treated. , Historically, OSA ... a technician directly monitoring a patient,s breathing.  Many who suspect they ...
... DIEGO , Jan. 28 Conatus Pharmaceuticals Inc. ... evaluating CTS-1027 in combination with pegylated interferon (Pegasys®) and ribavirin ... of the triple combination will be assessed after up to ... medical need in HCV patients who have not responded to ...
Cached Medicine Technology:NovaSom(R) Diagnostic System Can Assist in Raising Diagnosis Rate for Potentially Lethal Condition 2NovaSom(R) Diagnostic System Can Assist in Raising Diagnosis Rate for Potentially Lethal Condition 3Conatus Pharmaceuticals Initiates Phase II Clinical Trial in Combination With Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV) 2Conatus Pharmaceuticals Initiates Phase II Clinical Trial in Combination With Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV) 3
(Date:12/19/2014)... B. E. Smith, the only full-service leadership ... retained to lead a national chief financial officer ... Park, Colo. The top executive search firm in the ... than 900 healthcare executives into organizations. , Estes ... access hospital and level IV trauma center, with a ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 Hands On Mobile ... available. The Spa On Wheels has been transformed into ... from the outside world seems to disappear. The Virtual Tour ... massages, facials, spa parties, corporate events and more. , The ... Spa On Wheels which is actually an overhauled Winnebago. Marla ...
(Date:12/19/2014)... Slone Partners , a national recruitment firm ... and laboratory testing industries, has promoted Leslie Loveless ... announcement comes after a year of expansion by ... Boston and several new additions to the team. ... experience," said Adam Slone, Chief Executive Officer. “Diagnostics ...
(Date:12/19/2014)... 19, 2014 The Hermitage Club ... in Southern Vermont’s Deerfield Valley, announced today that it ... classic rock songs. , Three time Grammy Award ... private concert followed by a trail naming ceremony. Hermitage ... names include: “I’m Alright” the theme song for the ...
(Date:12/19/2014)... Amy Norton HealthDay ... Children born to moms who were exposed to high levels ... risk of developing autism, a U.S. study suggests. Researchers ... between 1990 and 2002, those exposed to the most air ... baby who later developed autism. And exposure during the third ...
Breaking Medicine News(10 mins):Health News:Estes Park Medical Center Retains B. E. Smith to Recruit New Chief Financial Officer 2Health News:Estes Park Medical Center Retains B. E. Smith to Recruit New Chief Financial Officer 3Health News:A Virtual Tour Of Hands On Mobile Massage Spa Is Now Available 2Health News:A Virtual Tour Of Hands On Mobile Massage Spa Is Now Available 3Health News:Slone Partners Promotes Leslie Loveless to Chief Operating Officer 2Health News:The Hermitage Club Officially Names Four Ski Trails after Iconic Rock Songs by Grammy Award Winner Kenny Loggins 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 3
... , , THURSDAY, Nov. 1 (HealthDay News) -- Heart disease ... for an individual,s brothers or sisters, too, U.S. researchers ... among brothers, the Johns Hopkins University team found. For ... chest pain from blocked arteries, the other is 20 ...
... SACRAMENTO, Calif., Nov. 1 Always Best Care ... California,areas. America,s premier In-Home Care, Assisted Living Placement ... seniors in Granada,Hills/Sherman Oaks can now rely on ... over a decade, a caring relationship has been ...
... Addition to Postal Service Social Awareness Stamp,Series, WASHINGTON, ... next year to help raise awareness about Alzheimer,s disease,as ... John,Potter announced today, on the first day of both ... "With the Alzheimer,s Awareness commemorative stamp, we,ll ask,Americans ...
... the current issue of Clinical Pharmacology & Therapeutics, ... Bioethics and Johns Hopkins Berman Institute of Bioethics ... vaccine debate, and its effects on ethical and ... was a major achievement for cervical cancer prevention ...
... program,s launch, study found , , THURSDAY, Nov. 1 (HealthDay ... Part D prescription drug benefit increased the number of ... $32 billion to Medicare, a new study concludes. , ... Health Affairs , the study authors noted that many ...
... a statement,from ADA President Mark J. Feldman:, "The ... Camp (R-MI) for introducing legislation that will help bring ... tribal areas,where too many people lack sufficient access to ... "The Native American Full Access to Dental Care ...
Cached Medicine News:Health News:Siblings Often Share Heart Risks 2Health News:Siblings Often Share Heart Risks 3Health News:Announcing Always Best Care Senior Services Expansion Into the Granada Hills/Sherman Oaks, California Areas 2Health News:Alzheimer's Disease to be Highlighted on Stamp Next Year 2Health News:A missed shot: The failure of HPV vaccination state requirements 2Health News:A missed shot: The failure of HPV vaccination state requirements 3Health News:Medicare Drug Plan Cost $32 Billion in 2006 2Health News:Medicare Drug Plan Cost $32 Billion in 2006 3Health News:Statement by ADA President Mark J. Feldman on the Native American Full Access to Dental Care Act 2
...
Bimod, acetabular cup "Xl" UHMWHDPE....
Metal on metal hip acetabular cups available for both cemented and cementless applications, the Biomet Merck metal on metal articulation hip system (M2aTM) combines proven materials with the latest i...
S-ROM acetabular cups provide a variety of geometrical options to help address many anatomical situations and defects....
Medicine Products: